Facilitated By

San Antonio Medical Foundation

A TRIAL COMPARING THE EFFICACY, PATIENT-REPORTED OUTCOMES AND SAFETY OF INSULIN DEGLUDEC 200 U/ML VS INSULIN GLARGINE IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS REQUIRING HIGH-DOSE INSULIN

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Cersosimo,Eugenio
Funded by
NOVO NORDISK PHARMACEUTICAL
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity